Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 6, 2009, Pages 2044-2051

  Forsblad d'Elia, Helena ^a,f   Carlsten, Hans ^a   Labrie, Fernand ^b   Konttinen, Yrjö T ^c,d,e   Ohlsson, Claes ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LAVAL UNIVERSITY   (Canada)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d ORTON Invalid Foundation   (Finland)

^e COXA Hospital for Joint Replacement ^*  (Finland)

^f UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANDROSTANOLONE; ANDROSTENEDIOL; ANDROSTENEDIONE; C REACTIVE PROTEIN; ESTRADIOL; ESTROGEN; ESTRONE; HEMOGLOBIN; LA ANTIBODY; PLACEBO; PRASTERONE; PRASTERONE SULFATE; RO ANTIBODY; SEX HORMONE; TESTOSTERONE;

ACNE; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DIZZINESS; DOUBLE BLIND PROCEDURE; DREAMING; DRUG EFFECT; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; DRY EYE; ERYTHROCYTE SEDIMENTATION RATE; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; ESTRONE BLOOD LEVEL; FEMALE; FLOW RATE; HEMOGLOBIN BLOOD LEVEL; HIRSUTISM; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; LEG CRAMP; LEUKOCYTE COUNT; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLITE; MORNING DOSAGE; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SALIVARY GLAND; SALIVATION; SCORING SYSTEM; SIALOADENITIS; SIDE EFFECT; SJOEGREN SYNDROME; SWEATING; TESTOSTERONE BLOOD LEVEL; TRANSIENT ISCHEMIC ATTACK; XEROSTOMIA;

EID: 66749136425     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0106     Document Type: Article

References (30)

1. Manoussakis MN, Moutsopoulos HM 2000 Sjogren's syndrome: autoimmune epithelitis. Baillieres Best Pract Res Clin Rheumatol 14:73-95 (Pubitemid 30353025)
2. Talal N 1987 Overview of Sjögren's syndrome. J Dent Res 66:672-674
3. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH 2002 Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554-558 (Pubitemid 34539104)
4. Masi AT 1995 Sex hormones and rheumatoid arthritis: cause or effect relationships in a complex pathophysiology? Clin Exp Rheumatol 13:227-240
5. Masi AT, Josipoviæ DB, Jefferson WE 1984 Low a drenal androgenic-anabolic steroids in women with rheumatoid arthritis (RA): gas-liquid chromatographic studies of RA patients and matched normal control women indicating decreased 11-deoxy-17-ketosteroid excretion. Semin Arthritis Rheum 14:1-23 (Pubitemid 14031458)
6. Straub RH, Zeuner M, Antoniou E, Schölmerich J, Lang B 1996 Dehydroepiandrosterone sulfate is positively correlated with soluble interleukin 2 receptor and soluble intercellular adhesion molecule in systemic lupus erythematosus. J Rheumatol 23:856-861 (Pubitemid 26160253)
7. Valtysdóttir ST, Wide L, Hällgren R 2001 Low serum dehydroepiandrosterone sulfate in women with primary Sjogren's syndrome as an isolated sign of impaired HPA axis function. J Rheumatol 28:1259-1265 (Pubitemid 32510496)
8. Sullivan DA, Bélanger A, Cermak JM, Bérubé R, Papas AS, Sullivan RM, Yamagami H, Dana MR, Labrie F 2003 Are women with Sjogren's syndrome androgen-deficient? J Rheumatol 30:2413-2419
9. Laine M, Porola P, Udby L, Kjeldsen L, Cowland JB, Borregaard N, Hietanen J, Ståhle M, Pihakari A, Konttinen YT 2007 Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjogren's syndrome. Arthritis Rheum 56:2575-2584 (Pubitemid 47237276)
10. Labrie F, Luu-The V, Bélanger A, Lin SX, Simard J, Pelletier G, Labrie C 2005 Is dehydroepiandrosterone a hormone? J Endocrinol 187:169-196
11. Labrie F, Bélanger A, Bélanger P, Bérubé R, Martel C, Cusan L, Gomez J, Candas B, Chaussade V, Castiel I, Deloche C, Leclaire J 2007 Metabolism of DHEA in postmenopausal women following percutaneous administration. J Steroid Biochem Mol Biol 103:178-188 (Pubitemid 46157181)
12. Labrie F, Bélanger A, Labrie C, Candas B, Cusan L, Gomez JL 2007 Bioavailability and metabolism of oral and percutaneous dehydroepiandrosterone in postmenopausal women. J Steroid Biochem Mol Biol 107:57-69 (Pubitemid 47362670)
13. Labrie F, Cusan L, Gomez JL, Martel C, Bérubé R, Bélanger P, Chaussade V, Deloche C, Leclaire J 2008 Changes in serum DHEA and eleven of its metabolites during 12-month percutaneous administration of DHEA. J Steroid Biochem Mol Biol 110:1-9
14. Dessein PH, Joffe BI, Stanwix AE, Moomal Z 2001 Hyposecretion of the adrenal androgen dehydroepiandrosterone sulfate and its relation to clinical variables in inflammatory arthritis. Arthritis Res 3:183-188 (Pubitemid 32303435)
15. Smets EM, Garssen B, Bonke B, De Haes JC 1995 The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39:315-325
16. Fürst CJ, Ahsberg E 2001 Dimensions of fatigue during radiotherapy. An application of the Multidimensional Fatigue Inventory. Support Care Cancer 9:355-360
17. Dawes C 1987 Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J Dent Res 66(Spec no.):648-653
18. Islander U, Hasséus B, Erlandsson MC, Jochems C, Skrtic SM, Lindberg M, Gustafsson JA, Ohlsson C, Carlsten H 2005 Estren promotes androgen phenotypes in primary lymphoid organs and submandibular glands. BMC Immunol 6:16 (Pubitemid 41418108)
19. Treister NS, Richards SM, Rowley P, Jensen RV, Sullivan DA 2006 Influence of testosterone on gene expression in the ovariectomized mouse submandibular gland. Eur J Oral Sci 114:328-336
20. Treister NS, Richards SM, Suzuki T, Jensen RV, Sullivan DA 2005 Influence of androgens on gene expression in the BALB/c mouse submandibular gland. J Dent Res 84:1187-1192
21. Sullivan DA, Sullivan BD, Evans JE, Schirra F, Yamagami H, Liu M, Richards SM, Suzuki T, Schaumberg DA, Sullivan RM, Dana MR 2002 Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye. Ann NY Acad Sci 966:211-222
22. Sator MO, Joura EA, Golaszewski T, Gruber D, Frigo P, Metka M, Hommer A, Huber JC 1998 Treatment of menopausal keratoconjunctivitis sicca with topical oestradiol. Br J Obstet Gynaecol 105:100-102 (Pubitemid 28025364)
23. Nordmark G, Bengtsson C, Larsson A, Karlsson FA, Sturfelt G, Rönnblom L 2005 Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus. Autoimmunity 38:531-540 (Pubitemid 43101787)
24. Petri MA, Mease PJ, Merrill JT, Lahita RG, Iannini MJ, Yocum DE, Ginzler EM, Katz RS, Gluck OS, Genovese MC, Van Vollenhoven R, Kalunian KC, Manzi S, Greenwald MW, Buyon JP, Olsen NJ, Schiff MH, Kavanaugh AF, Caldwell JR, Ramsey-Goldman R, St. Clair EW, Goldman AL, Egan RM, Polisson RP, Moder KG, Rothfield NF, Spencer RT, Hobbs K, Fessler BJ, Calabrese LH, Moreland LW, Cohen SB, Quarles BJ, Strand V, Gurwith M, Schwartz KE 2004 Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus. Arthritis Rheum 50:2858-2868
25. Petri MA, Lahita RG, Van Vollenhoven RF, Merrill JT, Schiff M, Ginzler EM, Strand V, Kunz A, Gorelick KJ, Schwartz KE 2002 Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 46:1820-1829 (Pubitemid 34774514)
26. Hartkamp A, Geenen R, Godaert GL, Bijl M, Bijlsma JW, Derksen RH 2004 The effect of dehydroepiandrosterone on lumbar spine bone mineral density in patients with quiescent systemic lupus erythematosus. Arthritis Rheum 50:3591-3595 (Pubitemid 39488684)
27. Jankowski CM, Gozansky WS, Schwartz RS, Dahl DJ, Kittelson JM, Scott SM, Van Pelt RE, Kohrt WM 2006 Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial. J Clin Endocrinol Metab 91:2986-2993 (Pubitemid 44271746)
28. Vandenput L, Labrie F, Mellström D, Swanson C, Knutsson T, Peeker R, Ljunggren O, Orwoll E, Eriksson AL, Damber JE, Ohlsson C 2007 Serum levels of specific glucuronidated androgen metabolites predict BMD and prostate volume in elderly men. J Bone Miner Res 22:220-227 (Pubitemid 46167792)
29. Hartkamp A, Geenen R, Godaert GL, Bootsma H, Kruize AA, Bijlsma JW, Derksen RH 2008 Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjogren syndrome: a randomised controlled trial. Ann Rheum Dis 67:91-97
30. Pillemer SR, Brennan MT, Sankar V, Leakan RA, Smith JA, Grisius M, Ligier S, Radfar L, Kok MR, Kingman A, Fox PC 2004 Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjogren's syndrome. Arthritis Rheum 51:601-604 (Pubitemid 39056248)